Education and debate: Making regulation responsive to commercial interests: streamlining drug industry watchdogs.

@article{Abraham2002EducationAD,
  title={Education and debate: Making regulation responsive to commercial interests: streamlining drug industry watchdogs.},
  author={John Abraham and Danielle Bardelay and Christophe Kopp and J D Kleinke and Emma Bennion},
  journal={BMJ},
  year={2002},
  volume={325 7373},
  pages={1164-9}
}
New prescription drugs are developed and tested for quality, safety, and efficacy by the pharmaceutical industry, and little or no drug testing is conducted by governments in modern industrialised countries. Governments have regulatory authorities which have a legal duty to protect public health by ensuring that new drugs are not licensed unless they are of… CONTINUE READING